These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 11762815)

  • 1. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance.
    Ruka W; Rutkowski P; Kaminska J; Rysinska A; Steffen J
    Ann Oncol; 2001 Oct; 12(10):1423-32. PubMed ID: 11762815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis.
    Rutkowski P; Kaminska J; Kowalska M; Ruka W; Steffen J
    Int J Cancer; 2002 Aug; 100(4):463-71. PubMed ID: 12115531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diagnostic and Prognostic Value of Hematological and Chemical Abnormalities in Soft Tissue Sarcoma: A Comparative Study in Patients with Benign and Malignant Soft Tissue Tumors.
    Ariizumi T; Kawashima H; Ogose A; Sasaki T; Hotta T; Hatano H; Morita T; Endo N
    Ann Clin Lab Sci; 2018 Jan; 48(1):11-17. PubMed ID: 29530991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
    Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas.
    Bien E; Rapala M; Krawczyk M; Balcerska A
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):293-305. PubMed ID: 19693535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum endostatin levels are elevated in patients with soft tissue sarcoma.
    Feldman AL; Pak H; Yang JC; Alexander HR; Libutti SK
    Cancer; 2001 Apr; 91(8):1525-9. PubMed ID: 11301401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
    Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of the changes in circulating cytokines, soluble cytokine receptors, and white blood cell subset counts in patients with rheumatoid arthritis (RA) after monoclonal anti-TNF alpha antibody therapy.
    Ohshima S; Saeki Y; Mima T; Sasai M; Nishioka K; Ishida H; Shimizu M; Suemura M; McCloskey R; Kishimoto T
    J Clin Immunol; 1999 Sep; 19(5):305-13. PubMed ID: 10535607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes.
    Mangge H; Kenzian H; Gallistl S; Neuwirth G; Liebmann P; Kaulfersch W; Beaufort F; Muntean W; Schauenstein K
    Arthritis Rheum; 1995 Feb; 38(2):211-20. PubMed ID: 7848311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival.
    Kowalska M; Kaminska J; Fuksiewicz M; Kotowicz B; Chechlinska M; Druzd-Sitek A; Walewski J
    Med Oncol; 2011 Mar; 28(1):194-8. PubMed ID: 20043215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
    Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
    Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
    Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
    Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
    Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
    Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.
    Gupta M; Stenson M; O'Byrne M; Maurer MJ; Habermann T; Cerhan JR; Weiner GW; Witzig TE
    Ann Oncol; 2016 Jan; 27(1):165-72. PubMed ID: 26487586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.
    Tefferi A; Vaidya R; Caramazza D; Finke C; Lasho T; Pardanani A
    J Clin Oncol; 2011 Apr; 29(10):1356-63. PubMed ID: 21300928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas.
    Asanuma K; Nakamura T; Asanuma Y; Kakimoto T; Yada Y; Hagi T; Kita K; Matsumine A; Sudo A
    Cancer Biomark; 2019; 26(2):163-170. PubMed ID: 31356193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory cytokines as serum biomarker in oral carcinoma-A prospective multi-biomarker approach.
    Schiegnitz E; Kämmerer PW; Schön H; Blatt S; Berres M; Sagheb K; Al-Nawas B
    J Oral Pathol Med; 2018 Mar; 47(3):268-274. PubMed ID: 29272054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in serum cytokine levels in patients with malignant bone and soft tissue tumors in the course of chemotherapy].
    Sato M; Kasai C; Takeuchi S; Takemura M; Shimokawa K; Noma A
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1449-52. PubMed ID: 1530291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression.
    Zekri AR; Ashour MS; Hassan A; Alam El-Din HM; El-Shehaby AM; Abu-Shady MA
    World J Gastroenterol; 2005 Nov; 11(42):6624-30. PubMed ID: 16425355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.